Rhythm Pharma shares fall as obesity drug trial fails to meet main goal

Investing.com Gold reports: Rhythm Pharma shares fall as obesity drug trial fails to meet main goal. This is a premium/paywalled source, so the brief is based on headline and available metadata only.